Companies Aktis Oncology
Aktis Oncology (AKTS): executive pay, fiscal 2023
Free brief. Every figure links to the company’s own filing.
Aktis Oncology no longer files a proxy statement; its last pay data is FY2023.
CEO pay, last three years
- $1,290,740FY2023
CEO total pay was $1,290,740 in fiscal 2023; the brief holds no earlier figure for this CEO.
FY2023: salary $470,730 · bonus $0 · stock awards $571,500 · option awards $0
Executives and directors
Frequently asked questions
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Jeffrey Shealy | $470,730 | $0 | $571,500 | $0 | $235,365 | $0 | $13,145 | $1,290,740 |
| Former Chief Executive Officer | ||||||||
| David Aichele | 258,308 | 0 | 439,350 | 0 | 77,493 | 0 | 12,721 | 787,872 |
| Former EVP of Business Development | ||||||||
| Kenneth Boller | 246,989 | 0 | 364,350 | 0 | 61,747 | 0 | 12,850 | 685,936 |
| Chief Financial Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2023 total | FY2022 total | FY2021 total | Δ FY2022→2023 |
|---|---|---|---|---|
| Jeffrey Shealy | $1,290,740 | — | — | — |
| David Aichele | 787,872 | — | — | — |
| Kenneth Boller | 685,936 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
The Company's executive compensation program is designed to attract, motivate and retain its executive officers, who are critical to its success.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Pearl Meyer & Partners |
| Clawback policy | — |
| Anti-hedging | — |
| Anti-pledging | — |
Equity grants and outstanding awards
Grants of plan-based awards — fiscal year 2023
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Jeffrey Shealy | RSU | 2023-09-26 | — | — | 40,000 | — | $129,600 |
| David Aichele | PSU | 2023-09-13 | — | — | 60,000 | — | 7,800 |
| David Aichele | RSU | 2023-09-13 | — | — | 40,000 | — | 90,000 |
| Kenneth Boller | RSU | 2023-09-13 | — | — | 40,000 | — | 90,000 |
| Kenneth Boller | PSU | 2023-09-13 | — | — | 60,000 | — | 7,800 |
| Jeffrey Shealy | PSU | 2023-09-26 | — | — | 120,000 | — | 15,600 |
Vehicle mix — grant-date fair value by award type
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Jeffrey Shealy | $129,600 | $15,600 | $0 | 10.7% |
| David Aichele | 90,000 | 7,800 | 0 | 8.0% |
| Kenneth Boller | 90,000 | 7,800 | 0 | 8.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
Outstanding equity awards at fiscal year-end 2023
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Kenneth Boller | RSU | 3,000 | — | $395 |
| Kenneth Boller | RSU | 4,000 | — | 527 |
| David Aichele | RSU | 4,000 | — | 527 |
| Jeffrey Shealy | RSU | 6,000 | — | 790 |
| Kenneth Boller | RSU | 6,000 | — | 790 |
| Jeffrey Shealy | Option | 6,000 | 7.98 | — |
| Kenneth Boller | RSU | 9,000 | — | 1,185 |
| Kenneth Boller | Option | 9,000 | 5.88 | — |
| David Aichele | RSU | 10,000 | — | 1,317 |
| Kenneth Boller | Option | 10,000 | 8.11 | — |
| David Aichele | RSU | 15,000 | — | 1,976 |
| Kenneth Boller | Option | 15,000 | 9.99 | — |
| David Aichele | Option | 16,000 | 8.11 | — |
| Jeffrey Shealy | RSU | 20,000 | — | 2,634 |
| Kenneth Boller | RSU | 20,000 | — | 2,634 |
| Jeffrey Shealy | Option | 20,000 | 8.11 | — |
| David Aichele | Option | 24,000 | 9.99 | — |
| David Aichele | RSU | 28,000 | — | 3,688 |
| Jeffrey Shealy | RSU | 30,000 | — | 3,951 |
| Jeffrey Shealy | Option | 30,000 | 10.15 | — |
| Kenneth Boller | RSU | 35,000 | — | 1,050 |
| David Aichele | RSU | 40,000 | — | 1,200 |
| Jeffrey Shealy | RSU | 40,000 | — | 5,268 |
| Kenneth Boller | RSU | 40,000 | — | 5,268 |
| Jeffrey Shealy | RSU | 50,000 | — | 1,500 |
| Kenneth Boller | RSU | 60,000 | — | 7,800 |
| David Aichele | RSU | 60,000 | — | 7,800 |
| Jeffrey Shealy | RSU | 80,000 | — | 10,536 |
| Jeffrey Shealy | RSU | 120,000 | — | 15,600 |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Jerry D. NealIndependent · Audit · Compensation (Chair) · Nominating (Chair) · IT Governance | $31,437 | $73,991 | — | — | — | $105,428 |
| Suzanne B. RudyIndependent | 27,062 | 63,694 | — | — | — | 90,756 |
| Michelle L. PetockIndependent | 23,125 | 0 | 63,775 | — | — | 86,900 |
| Arthur E. GeissIndependent · Technology (Chair) · IT Governance (Chair) | 0 | 81,395 | — | — | — | 81,395 |
| J. Michael McGuireIndependent | 20,875 | 49,131 | — | — | — | 70,006 |
| Steven P. DenBaarsIndependent · Technology · IT Governance | 19,125 | 22,506 | 26,372 | — | 0 | 68,003 |
| Jeffrey K. McMahonIndependent | 19,562 | 46,042 | — | — | — | 65,604 |
| Kamran S. CheemaEmployee director | — | — | — | — | — | 0 |
| Matthew R. KahnIndependent · Audit (Chair) · Compensation · Nominating | 0 | 0 | — | — | — | 0 |
| Jill K. FrizzleyIndependent · Audit · Compensation · Nominating | 0 | 0 | — | — | — | 0 |
Board fee structure and ownership guideline
| Annual cash retainer | $140,000 |
|---|---|
| Annual equity retainer | — |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 30,000 / 11,000 / 10,000 |
| Stock ownership guideline | — |
Total cost of the board
| Component | FY2023 |
|---|---|
| Cash retainers and fees | $141,186 |
| Equity awards (grant-date value) | $336,759 |
| All other compensation | $0 |
| Total cost of the board | $477,945 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names Aktis Oncology as a peer
Companies that benchmark against AKTS
1 company names AKTS as a compensation peer
- Atomera IncATOMFY2025
Each company listed discloses AKTS in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named AKTS in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Aktis Oncology | 2023 | Jeffrey Shealy | $470,730 | $571,500 | $0 | $235,365 | $1,290,740 |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Say-on-pay history and pay ratio
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2023 | 2023-11-02 | 22,016,577 | 7,499,406 | 548,372 | 74.59% | Passed |
| 2022 | 2022-11-10 | 18,675,169 | 5,331,822 | 151,266 | 77.79% | Passed |
| 2021 | 2021-10-28 | 20,589,023 | 822,008 | 416,622 | 96.16% | Passed |
| 2020 | 2020-10-29 | 11,904,797 | 937,870 | 256,777 | 92.7% | Passed |
| 2019 | 2019-11-04 | 12,338,040 | 2,021,161 | 97,130 | 85.92% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.
Say-on-pay — history, company’s computation
| Meeting year | Meeting date | Approval — company’s computation |
|---|---|---|
| 2023 | 2023-11-02 | 74.59%a |
| 2022 | 2022-11-10 | 77.79%b |
| 2021 | 2021-10-28 | 96.16%c |
a. Voting standard not stated in the filing.
b. Voting standard not stated in the filing.
c. Voting standard not stated in the filing.
Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
Insider trades since the proxy
No insider equity transactions reported since the proxy statement.
Sources (25 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Jeffrey Shealy. DEF 14A, filed 2024-10-08. Section “Executive Compensation”. As printed: 1,290,740. View filing ↗
- Section 01, David Aichele. DEF 14A, filed 2024-10-08. Section “Executive Compensation”. As printed: 787,872. View filing ↗
- Section 01, Kenneth Boller. DEF 14A, filed 2024-10-08. Section “Executive Compensation”. As printed: 685,936. View filing ↗
- Section 03, Jeffrey Shealy RSU. DEF 14A, filed 2024-10-08. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, David Aichele PSU. DEF 14A, filed 2024-10-08. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, David Aichele RSU. DEF 14A, filed 2024-10-08. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Kenneth Boller RSU. DEF 14A, filed 2024-10-08. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Kenneth Boller PSU. DEF 14A, filed 2024-10-08. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Jeffrey Shealy PSU. DEF 14A, filed 2024-10-08. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 08, Jerry D. Neal. DEF 14A, filed 2024-10-08. Section “Director Compensation”. As printed: 105,428. View filing ↗
- Section 08, Suzanne B. Rudy. DEF 14A, filed 2024-10-08. Section “Director Compensation”. As printed: 90,756. View filing ↗
- Section 08, Michelle L. Petock. DEF 14A, filed 2024-10-08. Section “Director Compensation”. As printed: 86,900. View filing ↗
- Section 08, Arthur E. Geiss. DEF 14A, filed 2024-10-08. Section “Director Compensation”. As printed: 81,395. View filing ↗
- Section 08, J. Michael McGuire. DEF 14A, filed 2024-10-08. Section “Director Compensation”. As printed: 70,006. View filing ↗
- Section 08, Steven P. DenBaars. DEF 14A, filed 2024-10-08. Section “Director Compensation”. As printed: 68,003. View filing ↗
- Section 08, Jeffrey K. McMahon. DEF 14A, filed 2024-10-08. Section “Director Compensation”. As printed: 65,604. View filing ↗
- Section 08, Kamran S. Cheema. DEF 14A, filed 2024-10-08. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 08, Matthew R. Kahn. DEF 14A, filed 2024-10-08. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 08, Jill K. Frizzley. DEF 14A, filed 2024-10-08. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 06, 2023 vote. Form 8-K, filed 2023-11-02. Item 5.07 · say-on-pay result. As reported: 74.59% (votes for as printed: 22,016,577). View filing ↗
- Section 06, 2022 vote. Form 8-K, filed 2022-11-14. Item 5.07 · say-on-pay result. As reported: 77.79% (votes for as printed: 18,675,169). View filing ↗
- Section 06, 2021 vote. Form 8-K, filed 2021-11-01. Item 5.07 · say-on-pay result. As reported: 96.16% (votes for as printed: 20,589,023). View filing ↗
- Section 03b vehicle mix (computed). Computed. RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).
- Section 09b board cost (computed). Computed. Cash 141,186 + equity 336,759 + all other 0 = 477,945, summed across the director compensation table rows.
- Aktis Oncology (subject), Section 10b CEO total. DEF 14A, filed 2024-10-08. CEO total compensation as printed in Aktis Oncology's own proxy. As printed: 1,290,740. View filing ↗